Mesa Laboratories (NASDAQ:MLAB) CAO Lyndsey Elizabeth Crennen Sells 118 Shares

Mesa Laboratories, Inc. (NASDAQ:MLAB) CAO Lyndsey Elizabeth Crennen sold 118 shares of the stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of $101.27, for a total value of $11,949.86. Following the completion of the sale, the chief accounting officer owned 1,473 shares of the company’s stock, valued at $149,170.71. The trade was a 7.42% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Mesa Laboratories Price Performance

MLAB stock traded down $4.85 during trading on Wednesday, reaching $94.84. The company’s stock had a trading volume of 154,655 shares, compared to its average volume of 136,917. Mesa Laboratories, Inc. has a 1 year low of $55.45 and a 1 year high of $113.99. The company has a quick ratio of 1.29, a current ratio of 1.72 and a debt-to-equity ratio of 0.78. The company has a market capitalization of $523.96 million, a P/E ratio of 79.03 and a beta of 0.94. The company’s fifty day moving average is $101.88 and its 200-day moving average is $90.54.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.78 by ($0.25). Mesa Laboratories had a return on equity of 20.96% and a net margin of 2.69%.The business had revenue of $63.72 million during the quarter, compared to analysts’ expectations of $65.21 million. During the same quarter in the previous year, the company posted ($1.31) EPS.

Mesa Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Friday, May 29th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Friday, May 29th. Mesa Laboratories’s dividend payout ratio is presently 53.33%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Mesa Laboratories currently has a consensus rating of “Reduce” and a consensus target price of $94.00.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in MLAB. Northwestern Mutual Wealth Management Co. grew its position in shares of Mesa Laboratories by 5,366.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 322 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in shares of Mesa Laboratories during the fourth quarter valued at about $27,000. Kestra Advisory Services LLC purchased a new position in shares of Mesa Laboratories during the fourth quarter valued at about $55,000. BNP Paribas Financial Markets grew its position in shares of Mesa Laboratories by 30.9% during the third quarter. BNP Paribas Financial Markets now owns 1,029 shares of the medical instruments supplier’s stock valued at $69,000 after purchasing an additional 243 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its position in shares of Mesa Laboratories by 432.9% during the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock valued at $79,000 after purchasing an additional 684 shares in the last quarter. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.